Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Comment by angeloeton May 11, 2022 9:11am
189 Views
Post# 34673473

RE:RE:RE:Great News!

RE:RE:RE:Great News!

I'm assuming that this was directed at me, under the pretense of replying to an alternate post? If you want to come at me, come at me straight. 2-3$ is not going to happen, and you know it. I thought that too, notice my previous posts about Hem, but also notice that I was pumping here at $0.20, and not $0.38. Both Caladrius and BioCardia have minimal to no warrants, and are much further along in their phase 3 studies, and are trading lower than this.

All I did, was point out the obvious. Its clear, that certain individuals on here and specifically on ceo.ca (sorry but I don't have an account there, and so decided to post here), are pumping to get an exit on higher priced shares, plenty of places to put your money in a market that has just crashed. And yes, I am long as well, but lets not play the fool shall we:) 

<< Previous
Bullboard Posts
Next >>